Skip to content

Attention Bias Modification for Transdiagnostic Anxiety

Neural Dimensions of Attention Bias Modification for Transdiagnostic Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02303691
Enrollment
70
Registered
2014-12-01
Start date
2013-04-30
Completion date
2018-01-31
Last updated
2018-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Anxiety Disorders

Keywords

anxiety, attention bias modification, computer

Brief summary

This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a focus on understanding the aspects of brain function that predict response to the treatment. This work could ultimately lead to the ability to treat anxiety more effectively by directly targeting the aspects of brain function that are altered in a given patient.

Interventions

BEHAVIORALAttention Bias Modification

Excessive attention to threat is theorized to be a critical contributor to chronic anxiety symptoms and related negative health consequences. Attention Bias Modification, which directly targets this mechanism, is a highly cost-effective intervention with growing empirical support for its potential efficacy in clinically anxious populations.

A control version of computerized attention training.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Completer analyses focused on prediction of active ABM outcomes using neural measures. Control arm used for effect size comparisons.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Participants will: 1. be between the ages of 18 and 55 years, 2. score \>45 on the Spielberger State-Trait Anxiety Inventory-trait form. 3. score \>=75th percentile on the World Health Organization Disability Assessment Schedule 2.0

Exclusion criteria

1. Current medication or Cognitive-Behavioral Therapy for anxiety or depression; 2. Failure to meet standard Magnetic Resonance Imaging (MRI) inclusion criteria: those who have cardiac pacemakers, neural pacemakers, surgical clips in the brain or blood vessels, surgically implanted metal plates, screws or pins, cochlear implants, Intrauterine Devices, metal braces, or other metal objects in their body, especially in the eye. If the subject has any metal or implants in the body they must be deemed safe by the MRI Research Center's safety screening procedure prior to enrollment. Dental fillings do not present a problem. Plastic or removable dental appliances do not require exclusion. Pregnancy, determined by pregnancy tests on females. 3. currently suicidal or at risk for harm to self or others, 4. visual disturbance (\<20/40 as per the Snellen test, corrective lenses allowed) 5. \<6th grade reading level as per the Wide Range Achievement Test 6. presence of bipolar, psychotic, autism spectrum, substance dependence, or primary depressive disorder 7. positive urine drug test

Design outcomes

Primary

MeasureTime frame
CAPS--Hypervigilance item1 month

Secondary

MeasureTime frameDescription
Mood and Anxiety Symptoms Questionnaire1 month
Mini International Neuropsychiatric Interview (MINI)1 month
Attentional bias towards threat (Performance-based assessment of attentional bias towards threat based on reaction times and eye tracking)immediatePerformance-based assessment of attentional bias towards threat based on reaction times and eye tracking
Penn State Worry Questionnaire1 month
Speilberger State-Trait Anxiety Inventory1 month
Beck Anxiety Inventory1 month
Liebowitz Social Anxiety Scale1 month
World Health Organization Disability Assessment Scale (WHODAS)1 month

Other

MeasureTime frameDescription
Functional Magnetic Resonance Imaging1 month(collected post-treatment in subsample of active arm only)
Pupillometry1 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026